stella
beta
JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders — Stella
Recruiting
Back to Autoimmune Diseases of the Nervous System trials
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
China
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei
View full record on ClinicalTrials.gov